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  Toll-like receptors (TLRs) functionally expressed in salivary epithelial cells, but their roles remain 
elusive. Among TLRs family, TLR3 is activated by dsRNA, a byproduct of viral infection. The aim 
of this study was to investigate the role of TLR3 in the inflammatory immune responses using HSG 
cells. Reverse transcriptase-polymerase chain reaction (RT-PCR), real-time PCR and ELISA were 
performed to identify expression of TLRs and TLR3-mediated chemokine inductions. The chemotaxis 
assay of activated T lymphocytes was also performed. Treatment of HSG cells with polyinosinic: poly-
cytidylic acid (poly(I:C)) significantly increased interferon-γ -inducible protein 10 (IP-10), interferon- 
inducible T-cell α chemoattractant (I-TAC), and regulated on activation, normal T-cells expressed and 
secreted (RANTES) gene expressions in a concentration-dependent manner. Anti-TLR3 antibody 
blocked the increases of IP-10 and I-TAC genes. Poly(I:C)-induced increases of IP-10 and I-TAC were 
also confirmed at protein levels from cell lysates, but their release into extracellular medium was 
detected only in IP-10. We found that the culture media from HSG cells stimulated with poly(I:C) 
significantly increases T lymphocyte migration. Our results suggest that TLR3 plays an important 
role in chemokine induction, particularly IP-10, in salivary epithelial cells. 
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INTRODUCTION
  Toll-like receptors (TLRs) are pathogen-recognition trans-
membrane receptors expressed on various types of cells, in-
cluding innate immune cells, such as macrophages and den-
dritic cells. The binding of specific ligands to TLRs induces 
not only the inflammatory responses but also the develop-
ment of the adaptive immune response. Currently, there 
are eleven known TLRs, from TLR1 to TLR11, that recog-
nize distinct pathogen molecular patterns, found in bac-
teria, viruses, and fungi. Particularly, double strand viral 
RNA (dsRNA) is recognized by TLR3 [1]. Binding of viral 
dsRNA to TLR3 initiates the innate immune response by 
the induction of IFN-α and IFN-β [2]. In addition, other 
inflammatory cytokines and chemokines, such as TNF-α, 
and IL-6, IL-12, IP-10, and RANTES, are also induced by 
TLR3 stimulation in fibroblast and mononuclear leukocytes 
[3] and lung epithelial cells [2,4]. However, the kinds of 
chemokines induced by TLR3 activation appear to depend 
on the cell type being stimulated. 
  Epithelial cells also express TLR and confer initiation of 
an immune response [5,6]. Salivary gland epithelial cells 
obtained from Sjogren’s syndrome (SS) patients show a 
40-fold higher mRNA expression level of pro-inflammatory 
cytokines, such as IL-1α, IL-6, TNF-α, compared to normal 
salivary gland epithelial cells [7]. Viral infection has been 
studied as one of the etiological factors of SS. Hepatitis C 
viral infection showed a strong correlation with SS in case 
report study [8]. Furthermore, anti-viral treatment for SS 
patients has shown a significant clinical benefit, suggesting 
that hepatitis C viral infection could be one of the etiological 
factors for SS [9].
  Our objectives in this study were to examine functional 
expression of TLRs in salivary epithelial cells, particularly 
focused on TLR3, which interacts with dsRNA. In this ex-
periments, we investigated roles of TLR3 in the inflam-
matory immune response in salivary gland epithelial cells. 
We found that TLR3 plays an important role in the immune 
response by releasing T-cell attractive chemokine, IP-10, in 
HSG cells. The result may provide a clue to explain the 
hypofunction of salivary glands, caused by viral infection. 
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METHODS
Cell culture
  HSG cells, originated from the human submandibular 
ducts, were grown in suspension in 6-well tissue culture 
plates at 37oC in 95% air-5% CO2, and were maintained 
in minimum essential medium (MEM) supplemented with 
10% fetal bovine serum (FBS). MEM and FBS were ob-
tained from GIBCO BRL (Long Island, NY, USA). Each 
plate was refreshed twice per week. Human submandibular 
glands (SMG) were obtained from five patients who had 
resection of the SMG for cure of malignant cancer. The pa-
tients included both males and females, with ages ranging 
from 35 to 70 years. The present study was approved by 
the Institutional Review Board (CRI06002) of Seoul National 
University Dental Hospital in Korea. 
RT-PCR of TLRs
  Total RNA was extracted from hSMG or HSG cell lines. 
Reverse transcription polymerase chain reaction (RT-PCR) 
was performed using an oligo dT reverse transcriptase pri-
mer and human TLRs specific primers. The primers used 
[forward, reverse, and product size (bp)] were as follows: 
Human TLR1 5'-CGTAAAACTGGAAGCTTTGCAAGA-3' and 
5'-CCTTGGGCCATTCCAAATAAGTCC-3' 890; hTLR2, 5'- 
GGCCAGCAAATTACCTGTGTG-3' and 5'-CCAGGTAGGT-
CTTGGTGTTCA-3' 615; hTLR3, 5'-ATTGGG TCTGGG AA-
CATTTCTC TTC-3' and 5'-GTGAGATTTAAACATTCCTCT-
TCGC-3' 303; hTLR4, 5'-CTGCAATGGATCAAGGACCA-3' 
and 5'-TCCCACTCCAGGTAAGTGTT-3' 623; hTLR5, 5'- 
CATTGTATGCACTG TCACTC-3' and 5'-CCACCACCATG-
ATGAGAGCA-3' 446; hTLR6, 5'-TAGGTCTCATGACGAA-
GGAT-3' and 5'-GGCCACTGCAAATAACTCCG-3' 1107; 
hTLR7, 5'-AGTGTCTAAAGAACCTGG-3' and 5'-CTTGGC-
CTTACAGAAATG-3' 545; hTLR8, 5'-CAGAATAGCAGGC-
GTAACACATCA-3' and 5'-AATGTCACAGGTGCATTCAA-
AGGG-3' 637; hTLR9, 5'-TTATGGACTTCCTGCTGGAGG-
TGC-3' and 5'-CTGCGTTTTGTCGAAGACCA-3' 332; hβ- 
actin, 5'-ATCTGGCA CCACACCTTCTACAATGAGCTGCG-3' 
and 5'-CGTCATACTCCTGCTTGCTGATCCACATC TGC-3' 
1163. Cycling parameters were as follows: a total 40 PCR 
cycles were performed, including 94oC 5 min, annealing 
from 65oC to 55oC for the first 10 cycles and 55oC for last 
30 cycles, and extension at 72oC for 55s. 
Real-time PCR
  Real-time PCR was performed as described in previous 
study [10]. The sequences of primers used were as follows. 
Human glyceraldehyde 3-phosphate dehydrogenase (GAPDH) 
forward: 5'-GGAGTCAACGGATTTGGTCGT-3', reverse: 5'- 
ACGGTGCCATGGAATTTGC-3', human interferon-γ-inducible 
protein 10 (IP-10) forward: 5'-TGCCGTCATTTTCTGCC-
TCA-3', reverse: 5'-TCACTGGCCCGTCATCGATAT-3', hu-
man interferon-inducible T-cell α chemoattractant (I-TAC) 
forward: 5'-CCTTGGCTGTGATATTGTGTGC-3', reverse: 5'- 
GCCACTTTCACTGCTTTTACCC-3', human Regulated on 
activation, normal T-cells expressed and secreted (RANTES) 
forward: 5'-CGTGCCCACATCAAGGAGTATT-3', reverse: 
5'-CCGAACCCATTTCTTCTCTGG-3'. The mRNA expression 
levels for each gene were presented as fold increases nor-
malized to the human GAPDH gene. 
Enzyme-linked immunosorbent assay (ELISA)
  Protein secretion of IP-10 and I-TAC from HSG cell lines 
upon stimulation of poly(I:C) were confirmed using an IP-10 
and I-TAC ELISA kit from R&D Systems (Minneapolis, 
MN, USA). 3.75×105 HSG cells/well were seeded in a 
12-well culture dish. Cells were treated with poly(I:C) for 
24 hrs, the culture supernatants were harvested, and 
ELISAs were performed. 
Isolation of peripheral blood mononuclear cells (PBMCs) 
  Heparinized peripheral blood mononuclear cells (PBMCs) 
from healthy donors were isolated by density gradient cen-
trifugation with Ficoll-Hypaque from Amersham Pharmacia 
Biotech (Uppsala, Sweden). To generate T lymphoblasts, 
PBMCs were stimulated with 5 μg/ml phytohemaglutinin 
from Sigma (St. Louis, MO, USA) for 48 hrs, and thereafter 
with IL-2 for 7 days. Cells were incubated in RPMI with 
10% FCS, 100 units/ml of penicillin, and 100 μg/ml of 
streptomycin.
Chemotaxis assay 
  Chemotaxis assays were performed using 24-well trans-
well chambers with polycarbonate filters from Corning 
Costar (Rochester, NY, USA). Activated T lymphocytes 
were added directly to the upper chambers of the transwell 
inserts at 1×105/0.1 ml in 10% FBS RPMI, and 600 μl HSG 
culture medium was added to the lower wells. Transwells 
were incubated for up to 3 hrs at 37oC in an atmosphere 
of 5% CO2 and 95% air. Transmigration was quantified by 
collecting PBMC from lower chambers and counting with 
a standard hemocytometer. For antibody neutralization ex-
periments, mouse monoclonal antibodies against IP-10 
(R&D Systems) were added to the transwell to a final con-
centration of 5 μg/ml. 
Statistical analysis
  The statistical significance of differences in different 
groups was tested using the unpaired Student’s t-test with 
a threshold of less than p＜0.01, *. 
RESULTS
Expression of TLRs in salivary epithelial cells 
　We tested expression of nine subtypes of TLRs (from 
TLR1 to TLR9) from human SMG(hSMG) and HSG cells 
using RT-PCR (Fig. 1). hSMG showed strong mRNA ex-
pressions of TLR1, 3, 5 and 9. It also expressed TLR 2, 
4, and 6 at a lower level. The experiment was repeated with 
5∼6 different human tissues obtained from the different 
patients. We confirmed that the expression patterns of 
TLRs in hSMG tissues were consistent. mRNA expression 
for TLRs was also tested in HSG cells, one of the most 
well-accepted salivary gland cell lines, originated from the 
human submandibular ducts. HSG cells also showed strong 
mRNA expression of TLR3, which is consistent with the 
pattern seen in hSMG tissues. TLR 1, 4, 5 and 6 expression 
was also observed in HSG cells. 
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Fig. 2. Poly(I:C)-induced mRNA expressions of IP-10, I-TAC, and RANTES in HSG cells. The means±S.E.M of three independent experiments 
are shown. (A∼C) Increase in chemokine gene expression in a concentration-dependent manner. Treatment of cells with 10 μg/ml poly(I:C) 
significantly increased (p＜0.01, indicated by *) induction of IP-10, I-TAC, and RANTES by 26.5±1.2, 28.6±10.0, and 5.6±0.9 folds (dark 
grey bar in A, B, C), respectively, compared to the control (Con). The high concentration of poly(I:C), 40 μg/ml, further increased inductions 
of these chemokines by 209.3±19.7, 216.2±88.3, and 57.6±4.7 folds, respectively (black bar in A, B, C). (D∼F) Expression levels of chemokine
genes in a various incubation time with 10 μg/ml of poly(I:C). Peak increases of all three chemokine expressions were observed after 
incubation of cells with poly(I:C) for 6 hrs by 68.3±2.3, 53±0.6, and 13.2±0.7 folds (p＜0.001, indicated by **), respectively (hatched bar 
in D, E, and F).
Fig. 1. mRNA expression of Toll like receptor (TLR) subtypes in 
human submandibular glands (hSMG) and HSG cell lines. (A) 
Strong mRNA expression of TLR1, 3, 5, and 9 and weak expression 
of TLR2, 4, and 6 in hSMG. M; marker protein, Pwon600DNA/ 
ECOR1+HinfI Digest N; negative control. (B) Strong mRNA 
expression of TLR1, 3 and 6, and weak expressions TLR4 and 5 
in HSG cell lines.
TLR3 mediated chemokine induction in HSG cells
  We then stimulated HSG cells with poly(I:C) to examine 
whether TLR3 mediates chemokine induction, particularly 
on IP-10, I-TAC and RANTES. The amount of chemokine 
mRNA transcripts was assed using real-time PCR. HSG 
cells were incubated with poly(I:C) for 6 hrs at various con-
centrations(Fig. 2A, B and C). Poly(I:C) increased chemo-
kine gene expression levels of IP-10 (A), I-TAC (B), and 
RANTES (C), in a concentration-dependant manner. 5 μg/ml 
poly(I:C) had little effect on the three chemokine mRNA 
transcripts, compared to the controls. However, mRNA ex-
pression levels of the three chemokines were significantly 
and concentration-dependently increased with poly(I:C) 
treatment at 10, 20, and 40 μg/ml concentrations. The low-
est concentration to induce a significant increase of mRNA 
expression of these three chemokine was 10 μg/ml (dark 
grey bar in Fig. 2A, B, and C). The high concentration of 
poly(I:C), 40 μg/ml (black bars), further increased in-
ductions of these chemokines. We then investigated ex-
pression levels of chemokine genes at various incubation 
times; 3, 6, 12 and 24 hrs incubation of HSG cells with 
10 μg/ml of poly(I:C). The peak increase in expression of 
all three chemokines was observed after incubation of cells 
with poly(I:C) for 6 hrs (hatched bar in Fig. 2D, E, and F). 
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Fig. 3. Effects of TLR3 antibody on the IP-10 (A), I-TAC (B), and RANTES (C) mRNA expression induced by 10 μg/ml poly(I:C) for 6 
hrs. The means±S.E.M of three independent experiments are shown. Poly(I:C)-induced inductions of IP-10, I-TAC and RANTES mRNA 
were decreased to 4.7±0.09, 1.4±0.3, and 14±5 folds, respectively, by the addition of 20 μg/ml TLR3 antibody (hatched bars). TLR3 antibody
significantly decreased IP-10 and I-TAC mRNA expression (p＜0.001, indicated by **), but not RANTES. Addition of mouse IgG (black 
bars) instead of TLR3 antibody has no effect on the expression of the three chemokine genes.
Fig. 4. Poly(I:C)-induced chemokine release and migration of 
activated T lymphocytes. The means±S.E.M of three independent 
experiments are shown. (A) I-TAC protein concentration from cell 
lysates in the control (C, 215±9.2 pg/ml), PMB (217.7±16.7 pg/ml), 
and poly(I:C) treatment groups. 10 μg/ml of poly(I:C) significantly 
increased protein concentration to 312.6±26.4 pg/ml (p＜0.01, 
indicated by *), compared to the control. (B) I-TAC protein con-
centrations in culture medium in control (C), PMB, and poly(I:C) 
treatment groups with 10, 20, and 40 μg/ml concentrations. The 
amount of I-TAC protein in the poly(I:C) treatment group was not 
significantly different, compared to the control or PMB groups (p＞
0.1). Note the different scale of Y-axis. (C) IP-10 protein concent-
rations in control (313.1±20.1 pg/ml), PMB (262.6±13.1 pg/ml), and 
poly(I:C) treatment groups in culture media. 10 μg/ml of poly(I:C) 
significantly increased protein concentration to 837.4±58.7 pg/ml 
(p＜0.001, indicated by *). (D) % migration of activated T lympho-
cytes induced by three different incubation media: untreated 
(control, white bar, 17.6±1.5%, n=3), treated with 10 μg/ml poly(I:C)
(grey bar, 31.3±2.0%, n=3), or plus antibodies against IP-10 (black 
bar, 18.3±1.5%, n=3). 10 μg/ml poly(I:C) significantly increased 
migration of activated T lymphocytes compared to the control 
(p＜0.01, indicated by *), and addition of anti-IP-10 Ab completely 
blocked the poly(I:C)-induced T lymphocyte migration. 
Inhibition of chemokine induction by anti-TLR3 antibody
  We next confirmed that poly(I:C)-induced chemokine ex-
pression is mediated by TLR3. We used a neutralizing an-
ti-TLR3 antibody that has been used for functional blocking 
of TLR3 [10]. For this experiment, we applied 20 μg/ml an-
ti-TLR3 antibody to the incubation medium 15 min before 
poly(I:C) application. Thereafter, the cells were further in-
cubated for 6 hrs. The addition of anti-TLR3 antibody al-
most completely blocked both 10 μg/ml poly(I:C)-induced 
IP-10 and I-TAC gene expression (hatched bar in Fig. 3A 
and B), compared to the control. However, anti-TLR3 anti-
body hardly blocked mRNA expression of RANTES (Fig. 3C). 
Poly(I:C)-induced chemokine release and migration of 
activated T lymphocytes 
  We examined whether poly(I:C) substantially produces 
and secrets IP-10 and I-TAC protein from HSG cells. The 
cells were incubated with poly(I:C) for 24 hrs at different 
concentrations. The amount of produced or secreted pro-
teins was analyzed from the culture media or cell lysate 
using ELISA. Although a significant increase of I-TAC 
protein was observed from cell lysates in a concentration 
dependent manner (Fig. 4A), they were hardly detected 
from the culture media (Fig. 4B. Note the different scale 
of Y-axis). The amount of I-TAC protein was not sig-
nificantly different compare to the control, or pretreated 
with polymyxin B (PMB) alone groups. We next examined 
poly(I:C)-induced release of IP-10 protein in the culture 
media. In contrast to I-TAC proteins, IP-10 proteins were 
detected in the culture media, increasing in a concen-
tration-dependent manner (Fig. 4C). We finally performed 
a chemotaxis assay to examine whether the treatment of 
HSG cells with poly(I:C) could induce the migration of T 
lymphocytes activated by phytohemaglutinin and IL-2. The 
culture supernatant from HSG cells stimulated with 10 μg/ml 
poly(I:C) revealed significantly increased migration, as 
compared with the control, untreated HSG cells(Fig. 4D). 
Conversely, addition of anti-IP-10 antibody into the culture 
supernatant significantly decreased the migration of T 
lymphocytes. 
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DISCUSSION
  Sicca symptoms, including dry mouth and dry eye, are 
among the main manifestations in primary Sjogren’s syn-
drome (pSS), suggesting that the salivary gland is a pri-
mary target organ in this disease. However, the etiology 
of the disease still remains elusive. Viral infection has been 
studied as one possible etiological factor for SS. In our ex-
periments, we focused on the TLR3, since it interacts with 
dsRNA, a byproduct of viral infection. Indeed, the viral eti-
ology for SS disease has been experimentally demonstrated 
[11], and expression of different TLRs in the salivary glands 
from patients with SS has been reported [12,13]. 
  In our experiments, poly(I:C) increased mRNA levels for 
chemokines, including IP-10, I-TAC, and RANTES, in a 
concentration-dependent manner. Among these chemokines, 
only IP-10 was detected at protein levels from the culture 
media. Its concentration was increased in a concentration- 
dependent manner, which is consistent with the observed 
mRNA levels. IP-10 is a member of the non-glutamic 
acid-leucine-arginine, CXC chemokine family produced by 
several cell types, particularly epithelial cells [14]. Its che-
moattractant function is mediated by a G-protein coupled 
receptor, chemokine (C-X-C motif) receptor 3 (CXCR3), 
which is primarily expressed in activated T-cells and NK 
cells [15]. TLR3 mediates a more potent antiviral responses 
than TLR4, and TLR3 is the primary target of the IRF-3 
transcription factor in the antiviral, dsRNA-dependent re-
sponse [15-17]. In our experiments, both poly(I:C)-mediated 
expression of IP-10 and I-TAC chemokines in cell lysates 
were inhibited by pre-incubation with an anti-TLR3 anti-
body, suggesting that TLR3 is functionally expressed, par-
ticipates in the recognition of dsRNA, and triggers down-
stream signals leading to chemokine expression. Since 
IP-10 and I-TAC share the same receptor, CXCR3, we also 
tested I-TAC protein levels. I-TAC protein in cell lysates 
was also increased by poly(I:C), but detected in a very small 
amount in culture media. The amount of I-TAC protein
(∼100 pg/ml) released into the medium was much lower 
than IP-10 protein (∼2,100 pg/ml). The result suggests that 
although a small amount of I-TAC protein has formed in-
side the cells, it is not released into the extracellular media. 
Thus, it appears that I-TAC is not a major chemoattractant 
for effector T cells in salivary glands as it is in primary 
human astrocytes [18]. Overall, our results strongly suggest 
that TLR3 plays an important role in salivary gland func-
tion, supporting previous work [19], and IP-10 is the major 
chemoattractant for T lymphocytes in HSG cells mediated 
by TLR3. Although RANTES mRNA expression was also 
increased by poly(I:C), it was not detected at the protein 
levels from cell lysates. It is possible that CCR5 (RANTES) 
is also involved in SS progress [20], but its increase is not 
related to TLR3 activation, and it may be induced by other 
unknown mechanisms. 
  Interestingly, CXCR3 and IP-10, Th1 chemoattractant 
chemokines, have been shown to have significantly higher 
expression in SS patients [21,22] than in normal healthy 
controls. Both IP-10 and I-TAC chemokines were mentioned 
as being involved in SS progression [23]. These mediators 
facilitate a cellular immune response that is required for 
the clearance of virus-infected cells. Saliva deficiency was 
detectable after cytomegalovirus infection [24], and a recent 
study showed that an antagonist of IP-10 ameliorates the 
progression of autoimmune sialadenitis in MRL/lpr mice 
[25]. Rifampicin inhibited the LPS-induced expression of 
TLR2 via the suppression of NF-kappaB DNA-binding ac-
tivity [26]. In our experiments, transcripts of TLR subtype 
families, including TLR3, were detected both in hSMG and 
HSG cells. Poly(I:C), a ligand for TLR3, increased expression 
of chemokine genes including IP-10, I-TAC and RANTES 
in HSG cells. Among these, a release of only IP-10 into the 
media was detected at protein levels and induced a migra-
tion of T lymphocytes. Therefore, the result suggests that 
dsRNA, a byproduct of viral infection, could be one of possi-
ble etiological factors in salivary gland dysfunction, and 
IP-10 appears to be the major chemoattractant for T lym-
phocytes in the inflammatory immune response mediated 
by TLR3. Although the further study is needed for proving 
a causal relationship between viral infection and SS, our 
result strongly suggests that TLR3 may play a role in sali-
vary gland dysfunction caused by autoimmune exocrinopathy. 
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